Filing Details
- Accession Number:
- 0001140361-13-004523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-05 09:13:01
- Reporting Period:
- 2013-01-31
- Filing Date:
- 2013-02-05
- Accepted Time:
- 2013-02-05 09:13:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1023869 | Merilee Raines | One Idexx Drive Westbrook ME 04092 | Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-01-31 | 47,576 | $95.27 | 45,500 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-01-31 | 7,500 | $95.96 | 38,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-01-31 | 27,216 | $95.46 | 39,159 | No | 4 | S | Indirect | by Charitable Remainder Trust |
Common Stock | Disposition | 2013-01-31 | 4,159 | $95.98 | 35,000 | No | 4 | S | Indirect | by Charitable Remainder Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | by Charitable Remainder Trust |
No | 4 | S | Indirect | by Charitable Remainder Trust |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.81 to $95.80, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, 4 and 5 to this Form 4.
- Excludes 10,870 and 42,075 shares previously owned directly, which were contributed to a Charitable Remainder Trust on 12/4/2012 and 1/23/2013, respectively.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.81 to $96.09, inclusive.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $94.83 to $95.8201, inclusive.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.83 to $96.09, inclusive.